The role of radiotherapy in multimodal treatment of pancreatic carcinoma

Por Brunner, Thomas B, Scott-Brown, Martin
Publicado em 2010

Gemcitabine/cisplatin versus 5-fluorouracil/mitomycin C chemoradiotherapy in locally advanced pancreatic cancer: a retrospective analysis of 93 patients

Por Brunner, Thomas B, Sauer, Rolf, Fietkau, Rainer
Publicado em 2011

Endobiliary Stent Position Changes during External-beam Radiotherapy

Por Chu, Kwun-Ye, Eccles, Cynthia L., Brunner, Thomas B.
Publicado no J Med Imaging Radiat Sci (2015)

IP-10/CXCL10 attracts regulatory T cells: Implication for pancreatic cancer

Por Lunardi, Serena, Lim, Su Yin, Muschel, Ruth J, Brunner, Thomas B
Publicado no Oncoimmunology (2015)

Pancreatic stellate cells radioprotect pancreatic cancer cells through β1-integrin signaling

Por Mantoni, Tine S., Lunardi, Serena, Al-Assar, Osama, Masamune, Atsushi, Brunner, Thomas B.
Publicado em 2011

Correlation of (18)F-Fluorodeoxyglucose Positron Emission Tomography Parameters with Patterns of Disease Progression in Locally Advanced Pancreatic Cancer after Definitive Chemorad...

Por Wilson, J.M., Mukherjee, S., Brunner, T.B., Partridge, M., Hawkins, M.A.
Publicado no Clin Oncol (R Coll Radiol) (2017)

Primary resection versus neoadjuvant chemoradiation followed by resection for locally resectable or potentially resectable pancreatic carcinoma without distant metastasis. A multi-...

Por Brunner, Thomas B, Grabenbauer, Gerhard G, Meyer, Thomas, Golcher, Henriette, Sauer, Rolf, Hohenberger, Werner
Publicado em 2007

Challenges in using (18) F-fluorodeoxyglucose-PET-CT to define a biological radiotherapy boost volume in locally advanced pancreatic cancer

Por Wilson, James M, Mukherjee, Somnath, Chu, Kwun-Ye, Brunner, Thomas B, Partridge, Mike, Hawkins, Maria
Publicado em 2014

Simultaneous integrated protection: A new concept for high-precision radiation therapy

Por Brunner, Thomas B., Nestle, Ursula, Adebahr, Sonja, Gkika, Eleni, Wiehle, Rolf, Baltas, Dimos, Grosu, Anca-Ligia
Publicado no Strahlenther Onkol (2016)

mHealth medication and blood pressure self-management program in Hispanic hypertensives: a proof of concept trial

Por Sieverdes JC, Gregoski M, Patel S, Williamson D, Brunner-Jackson B, Rundbaken J, Treiber E, Davidson L, Treiber FA
Publicado em 2013-10-01

Effect of a new angiotensin converting enzyme inhibitor MK 421 and its lysine analogue on the components of the renin system in healthy subjects.

Por Brunner, D B, Desponds, G, Biollaz, J, Keller, I, Ferber, F, Gavras, H, Brunner, H R, Schelling, J L
Publicado em 1981

The novel ATR inhibitor VE-821 increases sensitivity of pancreatic cancer cells to radiation and chemotherapy

Por Prevo, Remko, Fokas, Emmanouil, Reaper, Philip M., Charlton, Peter A., Pollard, John R., McKenna, W. Gillies, Muschel, Ruth J., Brunner, Thomas B.
Publicado em 2012

Enalapril maleate and a lysine analogue (MK-521) in normal volunteers; relationship between plasma drug levels and the renin angiotensin system.

Por Biollaz, J, Schelling, J L, Jacot Des Combes, B, Brunner, D B, Desponds, G, Brunner, H R, Ulm, E H, Hichens, M, Gomez, H J
Publicado em 1982

Oncogenic K-Ras Signals through Epidermal Growth Factor Receptor and Wild-Type H-Ras to Promote Radiation Survival in Pancreatic and Colorectal Carcinoma Cells

Por Cengel, Keith A., Voong, K. Rahn, Chandrasekaran, Sanjay, Maggiorella, Laurence, Brunner, Thomas B., Stanbridge, Eric, Kao, Gary D., McKenna, W. Gillies, Bernhard, Eric J.
Publicado em 2007

Neoadjuvant chemoradiation therapy with gemcitabine/cisplatin and surgery versus immediate surgery in resectable pancreatic cancer: Results of the first prospective randomized phas...

Por Golcher, Henriette, Brunner, Thomas B., Witzigmann, Helmut, Marti, Lukas, Bechstein, Wolf-Otto, Bruns, Christiane, Jungnickel, Henry, Schreiber, Stefan, Grabenbauer, Gerhard G., Meyer, Thomas, Merkel, Susanne, Fietkau, Rainer, Hohenberger, Werner
Publicado no Strahlenther Onkol (2014)

Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation

Por Fokas, E, Prevo, R, Pollard, J R, Reaper, P M, Charlton, P A, Cornelissen, B, Vallis, K A, Hammond, E M, Olcina, M M, Gillies McKenna, W, Muschel, R J, Brunner, T B
Publicado em 2012

Guidelines for preclinical and early phase clinical assessment of novel radiosensitisers

Por Harrington, K J, Billingham, L J, Brunner, T B, Burnet, N G, Chan, C S, Hoskin, P, Mackay, R I, Maughan, T S, Macdougall, J, McKenna, W G, Nutting, C M, Oliver, A, Plummer, R, Stratford, I J, Illidge, T
Publicado em 2011

ARCII: A phase II trial of the HIV protease inhibitor Nelfinavir in combination with chemoradiation for locally advanced inoperable pancreatic cancer

Por Wilson, James M., Fokas, Emmanouil, Dutton, Susan J., Patel, Neel, Hawkins, Maria A., Eccles, Cynthia, Chu, Kwun-Ye, Durrant, Lisa, Abraham, Aswin G., Partridge, Mike, Woodward, Martha, O’Neill, Eric, Maughan, Tim, McKenna, W. Gillies, Mukherjee, Somnath, Brunner, Thomas B.
Publicado no Radiother Oncol (2016)

IP-10/CXCL10 induction in human pancreatic cancer stroma influences lymphocytes recruitment and correlates with poor survival

Por Lunardi, Serena, Jamieson, Nigel B., Lim, Su Yin, Griffiths, Kristin L., Carvalho-Gaspar, Manuela, Al-Assar, Osama, Yameen, Sabira, Carter, Ross C., McKay, Colin J., Spoletini, Gabriele, D'Ugo, Stefano, Silva, Michael A., Sansom, Owen J., Janssen, Klaus-Peter, Muschel, Ruth J., Brunner, Thomas B.
Publicado no Oncotarget (2014)